INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
5.33
-0.95 (-15.13%)
At close: Jun 27, 2025, 4:00 PM
5.37
+0.04 (0.72%)
After-hours: Jun 27, 2025, 7:59 PM EDT
INmune Bio Employees
As of December 31, 2024, INmune Bio had 22 total employees, including 13 full-time and 9 part-time employees. The number of employees increased by 5 or 29.41% compared to the previous year.
Employees
22
Change (1Y)
5
Growth (1Y)
29.41%
Revenue / Employee
$2,273
Profits / Employee
-$1,854,364
Market Cap
123.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INMB News
- 4 hours ago - INmune Bio: Finding Pay Dirt In Alzheimer's? - Seeking Alpha
- 9 hours ago - INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 10 hours ago - INmune Bio Stock Soars Friday On Alzheimer's Treatment Hopes - Benzinga
- 1 day ago - INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer's on Monday, June 30th - GlobeNewsWire
- 11 days ago - INmune Bio: Imminent Phase 2 Alzheimer's Readout Of Unique Asset Presents Interesting Speculative Opportunity - Seeking Alpha
- 6 weeks ago - INmune Bio: XPro Trial Readout In Alzheimer's Disease Offers Big Opportunity - Seeking Alpha
- 6 weeks ago - INmune Bio, Inc. (INMB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update - GlobeNewsWire